BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29150437)

  • 1. Mechanism of activation of SGK3 by growth factors via the Class 1 and Class 3 PI3Ks.
    Malik N; Macartney T; Hornberger A; Anderson KE; Tovell H; Prescott AR; Alessi DR
    Biochem J; 2018 Jan; 475(1):117-135. PubMed ID: 29150437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
    Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
    Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoproteomics reveals that the hVPS34 regulated SGK3 kinase specifically phosphorylates endosomal proteins including Syntaxin-7, Syntaxin-12, RFIP4 and WDR44.
    Malik N; Nirujogi RS; Peltier J; Macartney T; Wightman M; Prescott AR; Gourlay R; Trost M; Alessi DR; Karapetsas A
    Biochem J; 2019 Oct; 476(20):3081-3107. PubMed ID: 31665227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth.
    Bago R; Sommer E; Castel P; Crafter C; Bailey FP; Shpiro N; Baselga J; Cross D; Eyers PA; Alessi DR
    EMBO J; 2016 Sep; 35(17):1902-22. PubMed ID: 27481935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinderella finds her shoe: the first Vps34 inhibitor uncovers a new PI3K-AGC protein kinase connection.
    Bilanges B; Vanhaesebroeck B
    Biochem J; 2014 Dec; 464(2):e7-10. PubMed ID: 25395352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro reconstitution of Sgk3 activation by phosphatidylinositol 3-phosphate.
    Pokorny D; Truebestein L; Fleming KD; Burke JE; Leonard TA
    J Biol Chem; 2021 Aug; 297(2):100919. PubMed ID: 34181950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
    Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Characterization of SGK3-PROTAC1, an Isoform Specific SGK3 Kinase PROTAC Degrader.
    Tovell H; Testa A; Zhou H; Shpiro N; Crafter C; Ciulli A; Alessi DR
    ACS Chem Biol; 2019 Sep; 14(9):2024-2034. PubMed ID: 31461270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the Phox homology domain and phosphorylation in activation of serum and glucocorticoid-regulated kinase-3.
    Tessier M; Woodgett JR
    J Biol Chem; 2006 Aug; 281(33):23978-89. PubMed ID: 16790420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
    Liu F; Wu X; Jiang X; Qian Y; Gao J
    J Exp Clin Cancer Res; 2018 Jun; 37(1):122. PubMed ID: 29940988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of SGK3 in PI3K/Pten driven liver tumor development.
    Cao H; Xu Z; Wang J; Cigliano A; Pilo MG; Ribback S; Zhang S; Qiao Y; Che L; Pascale RM; Calvisi DF; Chen X
    BMC Cancer; 2019 Apr; 19(1):343. PubMed ID: 30975125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum- and glucocorticoid-induced kinase 3 in recycling endosomes mediates acute activation of Na+/H+ exchanger NHE3 by glucocorticoids.
    He P; Lee SJ; Lin S; Seidler U; Lang F; Fejes-Toth G; Naray-Fejes-Toth A; Yun CC
    Mol Biol Cell; 2011 Oct; 22(20):3812-25. PubMed ID: 21865597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate.
    Gan X; Wang J; Su B; Wu D
    J Biol Chem; 2011 Apr; 286(13):10998-1002. PubMed ID: 21310961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endomembrane PtdIns(3,4,5)P3 activates the PI3K-Akt pathway.
    Jethwa N; Chung GH; Lete MG; Alonso A; Byrne RD; Calleja V; Larijani B
    J Cell Sci; 2015 Sep; 128(18):3456-65. PubMed ID: 26240177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class I PI3-kinase or Akt inhibition do not impair axonal polarization, but slow down axonal elongation.
    Diez H; Benitez MJ; Fernandez S; Torres-Aleman I; Garrido JJ; Wandosell F
    Biochim Biophys Acta; 2016 Nov; 1863(11):2574-2583. PubMed ID: 27421985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feedback Activation of SGK3 and AKT Contributes to Rapamycin Resistance by Reactivating mTORC1/4EBP1 Axis via TSC2 in Breast Cancer.
    Wang H; Huang F; Zhang Z; Wang P; Luo Y; Li H; Li N; Wang J; Zhou J; Wang Y; Li S
    Int J Biol Sci; 2019; 15(5):929-941. PubMed ID: 31182914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel integrin-activated pathway forms PKB/Akt-stimulatory phosphatidylinositol 3,4-bisphosphate via phosphatidylinositol 3-phosphate in platelets.
    Banfić H; Tang X; Batty IH; Downes CP; Chen C; Rittenhouse SE
    J Biol Chem; 1998 Jan; 273(1):13-6. PubMed ID: 9417038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of serum and glucocorticoid-regulated kinase 3 (SGK3) does not affect proliferation and survival of multiple myeloma cell lines.
    Hausmann S; Brandt E; Köchel C; Einsele H; Bargou RC; Seggewiss-Bernhardt R; Stühmer T
    PLoS One; 2015; 10(4):e0122689. PubMed ID: 25837824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
    Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
    Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.